MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Opioid dependence with other opioid-induced disorder (F11.288)

HealthDay 12 July at 03.43 PM

More Than Half Do Not Know Primary Care Providers Can Treat Opioid Use Disorder

Many people do not know that a primary care provider (PCP) can provide medication for opioid use disorder (MOUD), according to a research letter published online June 28 in JAMA Network Open.Brandon del Pozo, Ph.D., from the Brown University School of Public Health in Providence, Rhode Island, and colleagues surveyed 1,234 individu

HealthDay 08 January at 04.56 PM

Mindfulness-Oriented Recovery Enhancement Boosts Methadone Treatment

Telehealth-delivered mindfulness-oriented recovery enhancement (MORE) is a feasible and effective adjunct to methadone treatment (MT) for individuals with opioid use disorder (OUD) and pain, according to a study published online Dec. 7 in JAMA Psychiatry.Nina A. Cooperman, Psy.D., from Rutgers Robert Wood Johnson Medical School in P

HealthDay 08 January at 04.56 PM

Mindfulness-Oriented Recovery Enhancement Boosts Methadone Treatment

Telehealth-delivered mindfulness-oriented recovery enhancement (MORE) is a feasible and effective adjunct to methadone treatment (MT) for individuals with opioid use disorder (OUD) and pain, according to a study published online Dec. 7 in JAMA Psychiatry.Nina A. Cooperman, Psy.D., from Rutgers Robert Wood Johnson Medical School in P

HealthDay 02 January at 11.50 PM

Personalized Protocol Cuts Opioid Prescribing After C-Section

A personalized protocol for opioid prescriptions after cesarean delivery reduces the median morphine milligram equivalents prescribed at discharge, according to a study recently published in the American Journal of Obstetrics & Gynecology.Chinonye S. Imo, M.D., from Parkland Health in Dallas, and colleagues examined whether a transi

HealthDay 21 December at 11.17 PM

FDA Approves DNA Cheek Swab Test to ID Patients at High Risk for Opioid Addiction

The U.S. Food and Drug Administration has approved a first-of-its-kind test -- the AvertD test -- that uses DNA swabbed from a patient's cheek to determine if they have a combination of genetic variants associated with an elevated risk for opioid addiction.The 15 genetic variants detected by the test are involved in the brain reward pathways t

Evalytics 31 October at 04.46 PM

Telemedicine for Buprenorphine Initiation: Revolutionizing Opioid Use Disorder Treatment

In recent years, the healthcare industry has witnessed a transformative shift towards telemedicine. This innovative approach to healthcare delivery has proven to be not only convenient but also highly effective, especially in addressing complex issues like opioid use disorder. In this article, we will explore how telemedicine has revolutionized the initiation of buprenorphine treatment for individ